Matrix metalloproteinases in aortic dissection
Authors:
- 23 August 2024
- journal article
- review article
- Published by Elsevier in Vascular Pharmacology
- Vol. 156, 107420
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Matrix metalloproteinases in coronary artery disease and myocardial infarctionBasic Research in Cardiology, 2023
- Smooth Muscle Sirtuin 1 Blocks Thoracic Aortic Aneurysm/Dissection Development in MiceCardiovascular Drugs and Therapy, 2020
- Clinical and pathologic findings of aortic dissection at autopsy: Review of 336 cases over nearly 6 decadesAmerican Heart Journal, 2019
- Biochemical and Biological Attributes of Matrix Metalloproteinases2017
- The Balance Between Metalloproteinases and TIMPs2017
- Angiotensin-II induces phosphorylation of ERK1/2 and promotes aortic adventitial fibroblasts differentiating into myofibroblasts during aortic dissection formationJournal of Molecular Histology, 2013
- Impact of matrix metalloproteinase-8 gene variations on the risk of thoracic aortic dissection in a Chinese Han populationMolecular Biology Reports, 2013
- Up-regulation of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase were coupled with that of type I procollagen in granulation tissue response after the onset of aortic dissectionVirchows Archiv, 2006
- Relationship Between Circulating Plasma Matrix Metalloproteinase-9 (gelatinase-B) Concentration and Aortic Root DilatationAmerican Journal of Hypertension, 2006
- Decreased Tissue Inhibitor of Metalloproteinase-2/Matrix Metalloproteinase Ratio in the Acute Phase of Aortic DissectionSurgery Today, 2004